University of Texas's MD Anderson Cancer Center: Novel Therapy Could Help People With Asthma, COPD, Cystic Fibrosis and Cancer-Related Lung Disease
March 24, 2022
March 24, 2022
HOUSTON, Texas, March 24 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on March 23, 2022:
* * *
Experimental drug reduces airway mucus that exacerbates common lung diseases
* * *
A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threate . . .
* * *
Experimental drug reduces airway mucus that exacerbates common lung diseases
* * *
A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threate . . .